These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35293723)

  • 1. Global Exposure to Per- and Polyfluoroalkyl Substances and Associated Burden of Low Birthweight.
    Fan X; Tang S; Wang Y; Fan W; Ben Y; Naidu R; Dong Z
    Environ Sci Technol; 2022 Apr; 56(7):4282-4294. PubMed ID: 35293723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing exposure to legacy and emerging per- and polyfluoroalkyl substances via hair - The first nationwide survey in India.
    Ruan Y; Lalwani D; Kwok KY; Yamazaki E; Taniyasu S; Kumar NJI; Lam PKS; Yamashita N
    Chemosphere; 2019 Aug; 229():366-373. PubMed ID: 31078894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic, life-style and physiological determinants of serum per- and polyfluoroalkyl substance (PFAS) concentrations in a national cross-sectional survey of Swedish adolescents.
    Nyström J; Benskin JP; Plassmann M; Sandblom O; Glynn A; Lampa E; Gyllenhammar I; Moraeus L; Lignell S
    Environ Res; 2022 May; 208():112674. PubMed ID: 34998808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental Influences on Child Health Outcomes (ECHO) Program.
    Padula AM; Ning X; Bakre S; Barrett ES; Bastain T; Bennett DH; Bloom MS; Breton CV; Dunlop AL; Eick SM; Ferrara A; Fleisch A; Geiger S; Goin DE; Kannan K; Karagas MR; Korrick S; Meeker JD; Morello-Frosch R; O'Connor TG; Oken E; Robinson M; Romano ME; Schantz SL; Schmidt RJ; Starling AP; Zhu Y; Hamra GB; Woodruff TJ;
    Environ Health Perspect; 2023 Mar; 131(3):37006. PubMed ID: 36920051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of per- and polyfluoroalkyl substances (PFAS) in Norwegian children stratified by age and sex - Data from the Bergen Growth Study 2.
    Forthun IH; Roelants M; Haug LS; Knutsen HK; Schell LM; Jugessur A; Bjerknes R; Sabaredzovic A; Bruserud IS; Juliusson PB
    Int J Hyg Environ Health; 2023 Jul; 252():114199. PubMed ID: 37295275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic and exposure characteristics as predictors of serum per- and polyfluoroalkyl substances (PFASs) levels - A community-level biomonitoring project in Pennsylvania.
    Nair AS; Ma ZQ; Watkins SM; Wood SS
    Int J Hyg Environ Health; 2021 Jan; 231():113631. PubMed ID: 33035738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated daily intake of per- and polyfluoroalkyl substances related to different particle size fractions of house dust.
    Gustafsson Å; Bergman Å; Weiss JM
    Chemosphere; 2022 Sep; 303(Pt 2):135061. PubMed ID: 35649447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances.
    Porter AK; Kleinschmidt SE; Andres KL; Reusch CN; Krisko RM; Taiwo OA; Olsen GW; Longnecker MP
    Environ Int; 2022 Nov; 169():107537. PubMed ID: 36183490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Martinez D; Ibarluzea J; Santa-Marina L; Schettgen T; Vioque J; Sunyer J; Vrijheid M
    Environ Int; 2016; 92-93():357-65. PubMed ID: 27132161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing exposures to per- and polyfluoroalkyl substances in two populations of Great Lakes Basin fish consumers in Western New York State.
    Liu M; Nordstrom M; Forand S; Lewis-Michl E; Wattigney WA; Kannan K; Wang W; Irvin-Barnwell E; Hwang SA
    Int J Hyg Environ Health; 2022 Mar; 240():113902. PubMed ID: 34915281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Per- and polyfluoroalkyl substances in blood plasma - Results of the German Environmental Survey for children and adolescents 2014-2017 (GerES V).
    Duffek A; Conrad A; Kolossa-Gehring M; Lange R; Rucic E; Schulte C; Wellmitz J
    Int J Hyg Environ Health; 2020 Jul; 228():113549. PubMed ID: 32502942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort.
    Liew Z; Luo J; Nohr EA; Bech BH; Bossi R; Arah OA; Olsen J
    Environ Health Perspect; 2020 Apr; 128(4):47007. PubMed ID: 32319790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Historical human exposure to perfluoroalkyl acids in the United States and Australia reconstructed from biomonitoring data using population-based pharmacokinetic modelling.
    Gomis MI; Vestergren R; MacLeod M; Mueller JF; Cousins IT
    Environ Int; 2017 Nov; 108():92-102. PubMed ID: 28818713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine exposure to per- and polyfluoroalkyl substances may harm children's lung function development.
    Kung YP; Lin CC; Chen MH; Tsai MS; Hsieh WS; Chen PC
    Environ Res; 2021 Jan; 192():110178. PubMed ID: 32991923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Per- and polyfluoroalkyl substances (PFAS) in breast milk and infant formula: A global issue.
    LaKind JS; Naiman J; Verner MA; Lévêque L; Fenton S
    Environ Res; 2023 Feb; 219():115042. PubMed ID: 36529330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.